Global Pandemic Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 106

Published Date: 20 Sep 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Pandemic Influenza Vaccine market size is expected to reach $ 11570 million by 2029, rising at a market growth of 5.3% CAGR during the forecast period (2023-2029).

Global key players of Pandemic Influenza Vaccine include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.

This report studies the global Pandemic Influenza Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pandemic Influenza Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pandemic Influenza Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Pandemic Influenza Vaccine total production and demand, 2018-2029, (M Units)
Global Pandemic Influenza Vaccine total production value, 2018-2029, (USD Million)
Global Pandemic Influenza Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (M Units)
Global Pandemic Influenza Vaccine consumption by region & country, CAGR, 2018-2029 & (M Units)
U.S. VS China: Pandemic Influenza Vaccine domestic production, consumption, key domestic manufacturers and share
Global Pandemic Influenza Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (M Units)
Global Pandemic Influenza Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (M Units)
Global Pandemic Influenza Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (M Units).

This reports profiles key players in the global Pandemic Influenza Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and BCHT, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pandemic Influenza Vaccine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Pandemic Influenza Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Pandemic Influenza Vaccine Market, Segmentation by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Global Pandemic Influenza Vaccine Market, Segmentation by Application
6 Months to 3 Years
> 3 Years

Companies Profiled:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Key Questions Answered
1. How big is the global Pandemic Influenza Vaccine market?
2. What is the demand of the global Pandemic Influenza Vaccine market?
3. What is the year over year growth of the global Pandemic Influenza Vaccine market?
4. What is the production and production value of the global Pandemic Influenza Vaccine market?
5. Who are the key producers in the global Pandemic Influenza Vaccine market?

Table of Contents

1 Supply Summary
    1.1 Pandemic Influenza Vaccine Introduction
    1.2 World Pandemic Influenza Vaccine Supply & Forecast
        1.2.1 World Pandemic Influenza Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Pandemic Influenza Vaccine Production (2018-2029)
        1.2.3 World Pandemic Influenza Vaccine Pricing Trends (2018-2029)
    1.3 World Pandemic Influenza Vaccine Production by Region (Based on Production Site)
        1.3.1 World Pandemic Influenza Vaccine Production Value by Region (2018-2029)
        1.3.2 World Pandemic Influenza Vaccine Production by Region (2018-2029)
        1.3.3 World Pandemic Influenza Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Pandemic Influenza Vaccine Production (2018-2029)
        1.3.5 Europe Pandemic Influenza Vaccine Production (2018-2029)
        1.3.6 China Pandemic Influenza Vaccine Production (2018-2029)
        1.3.7 Japan Pandemic Influenza Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Pandemic Influenza Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Pandemic Influenza Vaccine Major Market Trends

2 Demand Summary
    2.1 World Pandemic Influenza Vaccine Demand (2018-2029)
    2.2 World Pandemic Influenza Vaccine Consumption by Region
        2.2.1 World Pandemic Influenza Vaccine Consumption by Region (2018-2023)
        2.2.2 World Pandemic Influenza Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Pandemic Influenza Vaccine Consumption (2018-2029)
    2.4 China Pandemic Influenza Vaccine Consumption (2018-2029)
    2.5 Europe Pandemic Influenza Vaccine Consumption (2018-2029)
    2.6 Japan Pandemic Influenza Vaccine Consumption (2018-2029)
    2.7 South Korea Pandemic Influenza Vaccine Consumption (2018-2029)
    2.8 ASEAN Pandemic Influenza Vaccine Consumption (2018-2029)
    2.9 India Pandemic Influenza Vaccine Consumption (2018-2029)

3 World Pandemic Influenza Vaccine Manufacturers Competitive Analysis
    3.1 World Pandemic Influenza Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Pandemic Influenza Vaccine Production by Manufacturer (2018-2023)
    3.3 World Pandemic Influenza Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Pandemic Influenza Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Pandemic Influenza Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Pandemic Influenza Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Pandemic Influenza Vaccine in 2022
    3.6 Pandemic Influenza Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Pandemic Influenza Vaccine Market: Region Footprint
        3.6.2 Pandemic Influenza Vaccine Market: Company Product Type Footprint
        3.6.3 Pandemic Influenza Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Pandemic Influenza Vaccine Production Value Comparison
        4.1.1 United States VS China: Pandemic Influenza Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Pandemic Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Pandemic Influenza Vaccine Production Comparison
        4.2.1 United States VS China: Pandemic Influenza Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Pandemic Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Pandemic Influenza Vaccine Consumption Comparison
        4.3.1 United States VS China: Pandemic Influenza Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Pandemic Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Pandemic Influenza Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Pandemic Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Pandemic Influenza Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Pandemic Influenza Vaccine Production (2018-2023)
    4.5 China Based Pandemic Influenza Vaccine Manufacturers and Market Share
        4.5.1 China Based Pandemic Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Pandemic Influenza Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Pandemic Influenza Vaccine Production (2018-2023)
    4.6 Rest of World Based Pandemic Influenza Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Pandemic Influenza Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Pandemic Influenza Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Pandemic Influenza Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Pandemic Influenza Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Trivalent Influenza Vaccine
        5.2.2 Quadrivalent Influenza Vaccine
    5.3 Market Segment by Type
        5.3.1 World Pandemic Influenza Vaccine Production by Type (2018-2029)
        5.3.2 World Pandemic Influenza Vaccine Production Value by Type (2018-2029)
        5.3.3 World Pandemic Influenza Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Pandemic Influenza Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 6 Months to 3 Years
        6.2.2 > 3 Years
    6.3 Market Segment by Application
        6.3.1 World Pandemic Influenza Vaccine Production by Application (2018-2029)
        6.3.2 World Pandemic Influenza Vaccine Production Value by Application (2018-2029)
        6.3.3 World Pandemic Influenza Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Details
        7.1.2 Sanofi Major Business
        7.1.3 Sanofi Pandemic Influenza Vaccine Product and Services
        7.1.4 Sanofi Pandemic Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Sanofi Recent Developments/Updates
        7.1.6 Sanofi Competitive Strengths & Weaknesses
    7.2 CSL
        7.2.1 CSL Details
        7.2.2 CSL Major Business
        7.2.3 CSL Pandemic Influenza Vaccine Product and Services
        7.2.4 CSL Pandemic Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 CSL Recent Developments/Updates
        7.2.6 CSL Competitive Strengths & Weaknesses
    7.3 GSK
        7.3.1 GSK Details
        7.3.2 GSK Major Business
        7.3.3 GSK Pandemic Influenza Vaccine Product and Services
        7.3.4 GSK Pandemic Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 GSK Recent Developments/Updates
        7.3.6 GSK Competitive Strengths & Weaknesses
    7.4 Viatris
        7.4.1 Viatris Details
        7.4.2 Viatris Major Business
        7.4.3 Viatris Pandemic Influenza Vaccine Product and Services
        7.4.4 Viatris Pandemic Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Viatris Recent Developments/Updates
        7.4.6 Viatris Competitive Strengths & Weaknesses
    7.5 AstraZeneca
        7.5.1 AstraZeneca Details
        7.5.2 AstraZeneca Major Business
        7.5.3 AstraZeneca Pandemic Influenza Vaccine Product and Services
        7.5.4 AstraZeneca Pandemic Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 AstraZeneca Recent Developments/Updates
        7.5.6 AstraZeneca Competitive Strengths & Weaknesses
    7.6 Hualan Bio
        7.6.1 Hualan Bio Details
        7.6.2 Hualan Bio Major Business
        7.6.3 Hualan Bio Pandemic Influenza Vaccine Product and Services
        7.6.4 Hualan Bio Pandemic Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Hualan Bio Recent Developments/Updates
        7.6.6 Hualan Bio Competitive Strengths & Weaknesses
    7.7 Changchun Institute of Biological
        7.7.1 Changchun Institute of Biological Details
        7.7.2 Changchun Institute of Biological Major Business
        7.7.3 Changchun Institute of Biological Pandemic Influenza Vaccine Product and Services
        7.7.4 Changchun Institute of Biological Pandemic Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Changchun Institute of Biological Recent Developments/Updates
        7.7.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
    7.8 Sinovac
        7.8.1 Sinovac Details
        7.8.2 Sinovac Major Business
        7.8.3 Sinovac Pandemic Influenza Vaccine Product and Services
        7.8.4 Sinovac Pandemic Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Sinovac Recent Developments/Updates
        7.8.6 Sinovac Competitive Strengths & Weaknesses
    7.9 BCHT
        7.9.1 BCHT Details
        7.9.2 BCHT Major Business
        7.9.3 BCHT Pandemic Influenza Vaccine Product and Services
        7.9.4 BCHT Pandemic Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 BCHT Recent Developments/Updates
        7.9.6 BCHT Competitive Strengths & Weaknesses
    7.10 Jiangsu GDK
        7.10.1 Jiangsu GDK Details
        7.10.2 Jiangsu GDK Major Business
        7.10.3 Jiangsu GDK Pandemic Influenza Vaccine Product and Services
        7.10.4 Jiangsu GDK Pandemic Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Jiangsu GDK Recent Developments/Updates
        7.10.6 Jiangsu GDK Competitive Strengths & Weaknesses
    7.11 KM Biologics
        7.11.1 KM Biologics Details
        7.11.2 KM Biologics Major Business
        7.11.3 KM Biologics Pandemic Influenza Vaccine Product and Services
        7.11.4 KM Biologics Pandemic Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 KM Biologics Recent Developments/Updates
        7.11.6 KM Biologics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Pandemic Influenza Vaccine Industry Chain
    8.2 Pandemic Influenza Vaccine Upstream Analysis
        8.2.1 Pandemic Influenza Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Pandemic Influenza Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Pandemic Influenza Vaccine Production Mode
    8.6 Pandemic Influenza Vaccine Procurement Model
    8.7 Pandemic Influenza Vaccine Industry Sales Model and Sales Channels
        8.7.1 Pandemic Influenza Vaccine Sales Model
        8.7.2 Pandemic Influenza Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Pandemic Influenza Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Pandemic Influenza Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Pandemic Influenza Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Pandemic Influenza Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Pandemic Influenza Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Pandemic Influenza Vaccine Production by Region (2018-2023) & (M Units)
    Table 7. World Pandemic Influenza Vaccine Production by Region (2024-2029) & (M Units)
    Table 8. World Pandemic Influenza Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Pandemic Influenza Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Pandemic Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Pandemic Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Pandemic Influenza Vaccine Major Market Trends
    Table 13. World Pandemic Influenza Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (M Units)
    Table 14. World Pandemic Influenza Vaccine Consumption by Region (2018-2023) & (M Units)
    Table 15. World Pandemic Influenza Vaccine Consumption Forecast by Region (2024-2029) & (M Units)
    Table 16. World Pandemic Influenza Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Pandemic Influenza Vaccine Producers in 2022
    Table 18. World Pandemic Influenza Vaccine Production by Manufacturer (2018-2023) & (M Units)
    Table 19. Production Market Share of Key Pandemic Influenza Vaccine Producers in 2022
    Table 20. World Pandemic Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Pandemic Influenza Vaccine Company Evaluation Quadrant
    Table 22. World Pandemic Influenza Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Pandemic Influenza Vaccine Production Site of Key Manufacturer
    Table 24. Pandemic Influenza Vaccine Market: Company Product Type Footprint
    Table 25. Pandemic Influenza Vaccine Market: Company Product Application Footprint
    Table 26. Pandemic Influenza Vaccine Competitive Factors
    Table 27. Pandemic Influenza Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Pandemic Influenza Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Pandemic Influenza Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Pandemic Influenza Vaccine Production Comparison, (2018 & 2022 & 2029) & (M Units)
    Table 31. United States VS China Pandemic Influenza Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (M Units)
    Table 32. United States Based Pandemic Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Pandemic Influenza Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Pandemic Influenza Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Pandemic Influenza Vaccine Production (2018-2023) & (M Units)
    Table 36. United States Based Manufacturers Pandemic Influenza Vaccine Production Market Share (2018-2023)
    Table 37. China Based Pandemic Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Pandemic Influenza Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Pandemic Influenza Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Pandemic Influenza Vaccine Production (2018-2023) & (M Units)
    Table 41. China Based Manufacturers Pandemic Influenza Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Pandemic Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Pandemic Influenza Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Pandemic Influenza Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Pandemic Influenza Vaccine Production (2018-2023) & (M Units)
    Table 46. Rest of World Based Manufacturers Pandemic Influenza Vaccine Production Market Share (2018-2023)
    Table 47. World Pandemic Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Pandemic Influenza Vaccine Production by Type (2018-2023) & (M Units)
    Table 49. World Pandemic Influenza Vaccine Production by Type (2024-2029) & (M Units)
    Table 50. World Pandemic Influenza Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Pandemic Influenza Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Pandemic Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Pandemic Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Pandemic Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Pandemic Influenza Vaccine Production by Application (2018-2023) & (M Units)
    Table 56. World Pandemic Influenza Vaccine Production by Application (2024-2029) & (M Units)
    Table 57. World Pandemic Influenza Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Pandemic Influenza Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Pandemic Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Pandemic Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 62. Sanofi Major Business
    Table 63. Sanofi Pandemic Influenza Vaccine Product and Services
    Table 64. Sanofi Pandemic Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Sanofi Recent Developments/Updates
    Table 66. Sanofi Competitive Strengths & Weaknesses
    Table 67. CSL Basic Information, Manufacturing Base and Competitors
    Table 68. CSL Major Business
    Table 69. CSL Pandemic Influenza Vaccine Product and Services
    Table 70. CSL Pandemic Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. CSL Recent Developments/Updates
    Table 72. CSL Competitive Strengths & Weaknesses
    Table 73. GSK Basic Information, Manufacturing Base and Competitors
    Table 74. GSK Major Business
    Table 75. GSK Pandemic Influenza Vaccine Product and Services
    Table 76. GSK Pandemic Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. GSK Recent Developments/Updates
    Table 78. GSK Competitive Strengths & Weaknesses
    Table 79. Viatris Basic Information, Manufacturing Base and Competitors
    Table 80. Viatris Major Business
    Table 81. Viatris Pandemic Influenza Vaccine Product and Services
    Table 82. Viatris Pandemic Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Viatris Recent Developments/Updates
    Table 84. Viatris Competitive Strengths & Weaknesses
    Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 86. AstraZeneca Major Business
    Table 87. AstraZeneca Pandemic Influenza Vaccine Product and Services
    Table 88. AstraZeneca Pandemic Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. AstraZeneca Recent Developments/Updates
    Table 90. AstraZeneca Competitive Strengths & Weaknesses
    Table 91. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 92. Hualan Bio Major Business
    Table 93. Hualan Bio Pandemic Influenza Vaccine Product and Services
    Table 94. Hualan Bio Pandemic Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Hualan Bio Recent Developments/Updates
    Table 96. Hualan Bio Competitive Strengths & Weaknesses
    Table 97. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
    Table 98. Changchun Institute of Biological Major Business
    Table 99. Changchun Institute of Biological Pandemic Influenza Vaccine Product and Services
    Table 100. Changchun Institute of Biological Pandemic Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Changchun Institute of Biological Recent Developments/Updates
    Table 102. Changchun Institute of Biological Competitive Strengths & Weaknesses
    Table 103. Sinovac Basic Information, Manufacturing Base and Competitors
    Table 104. Sinovac Major Business
    Table 105. Sinovac Pandemic Influenza Vaccine Product and Services
    Table 106. Sinovac Pandemic Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Sinovac Recent Developments/Updates
    Table 108. Sinovac Competitive Strengths & Weaknesses
    Table 109. BCHT Basic Information, Manufacturing Base and Competitors
    Table 110. BCHT Major Business
    Table 111. BCHT Pandemic Influenza Vaccine Product and Services
    Table 112. BCHT Pandemic Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. BCHT Recent Developments/Updates
    Table 114. BCHT Competitive Strengths & Weaknesses
    Table 115. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
    Table 116. Jiangsu GDK Major Business
    Table 117. Jiangsu GDK Pandemic Influenza Vaccine Product and Services
    Table 118. Jiangsu GDK Pandemic Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Jiangsu GDK Recent Developments/Updates
    Table 120. KM Biologics Basic Information, Manufacturing Base and Competitors
    Table 121. KM Biologics Major Business
    Table 122. KM Biologics Pandemic Influenza Vaccine Product and Services
    Table 123. KM Biologics Pandemic Influenza Vaccine Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Global Key Players of Pandemic Influenza Vaccine Upstream (Raw Materials)
    Table 125. Pandemic Influenza Vaccine Typical Customers
    Table 126. Pandemic Influenza Vaccine Typical Distributors
List of Figure
    Figure 1. Pandemic Influenza Vaccine Picture
    Figure 2. World Pandemic Influenza Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Pandemic Influenza Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Pandemic Influenza Vaccine Production (2018-2029) & (M Units)
    Figure 5. World Pandemic Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Pandemic Influenza Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Pandemic Influenza Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Pandemic Influenza Vaccine Production (2018-2029) & (M Units)
    Figure 9. Europe Pandemic Influenza Vaccine Production (2018-2029) & (M Units)
    Figure 10. China Pandemic Influenza Vaccine Production (2018-2029) & (M Units)
    Figure 11. Japan Pandemic Influenza Vaccine Production (2018-2029) & (M Units)
    Figure 12. Pandemic Influenza Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Pandemic Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 15. World Pandemic Influenza Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States Pandemic Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 17. China Pandemic Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 18. Europe Pandemic Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 19. Japan Pandemic Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 20. South Korea Pandemic Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 21. ASEAN Pandemic Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 22. India Pandemic Influenza Vaccine Consumption (2018-2029) & (M Units)
    Figure 23. Producer Shipments of Pandemic Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Pandemic Influenza Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Pandemic Influenza Vaccine Markets in 2022
    Figure 26. United States VS China: Pandemic Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Pandemic Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Pandemic Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Pandemic Influenza Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers Pandemic Influenza Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Pandemic Influenza Vaccine Production Market Share 2022
    Figure 32. World Pandemic Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Pandemic Influenza Vaccine Production Value Market Share by Type in 2022
    Figure 34. Trivalent Influenza Vaccine
    Figure 35. Quadrivalent Influenza Vaccine
    Figure 36. World Pandemic Influenza Vaccine Production Market Share by Type (2018-2029)
    Figure 37. World Pandemic Influenza Vaccine Production Value Market Share by Type (2018-2029)
    Figure 38. World Pandemic Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World Pandemic Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Pandemic Influenza Vaccine Production Value Market Share by Application in 2022
    Figure 41. 6 Months to 3 Years
    Figure 42. > 3 Years
    Figure 43. World Pandemic Influenza Vaccine Production Market Share by Application (2018-2029)
    Figure 44. World Pandemic Influenza Vaccine Production Value Market Share by Application (2018-2029)
    Figure 45. World Pandemic Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 46. Pandemic Influenza Vaccine Industry Chain
    Figure 47. Pandemic Influenza Vaccine Procurement Model
    Figure 48. Pandemic Influenza Vaccine Sales Model
    Figure 49. Pandemic Influenza Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Related Reports

Global Pandemic Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Pandemic Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 11 Mar 2021

date Pharma & Healthcare

The Pandemic Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Pandemic Influenza Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Pandemic Influenza Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 05 Jan 2022

date Pharma & Healthcare

Global Pandemic Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Pandemic Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 20 Sep 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pandemic Influenza Vaccine market size was valued at USD 8056.5 million in 2022 and is forecast to a readjusted size of USD 11570 million by 2029 with a CAGR of 5.3% during review period.

Global Pandemic Influenza Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Pandemic Influenza Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pandemic Influenza Vaccine market size was valued at USD 8056.5 million in 2023 and is forecast to a readjusted size of USD 11570 million by 2030 with a CAGR of 5.3% during review period.

Global Pandemic Influenza Vaccine Supply, Demand and Key Producers, 2024-2030

Global Pandemic Influenza Vaccine Supply, Demand and Key Producers, 2024-2030

date 02 Apr 2024

date Pharma & Healthcare

The global Pandemic Influenza Vaccine market size is expected to reach $ 11570 million by 2030, rising at a market growth of 5.3% CAGR during the forecast period (2024-2030).

Product Tags

pandemic influenza vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>